Huang Pu Da Dao Xi 601, Tian He District
Guangzhou, 510632
China
Jinan University
GSPT1, protein degradation, molecular glue, cancer
Pan-FGFR inhibitors, covalent binding, 5-amino-1H-pyrazole-4-carboxamide, Gatekeeper mutation, structure-based drug design.
FGFR4, hepatocellular carcinoma, clinical resistance mutations, covalent binding
Tuberculosis, cytochrome bd Oxidase, inhibitors, combinational therapy
ROR1, Pseudokinase, PROTACs, Protein Degradation, Apoptosis, Proliferation, NSCLC
HPK1, Kinase inhibitor, Cancer immunotherapy, Selectivity, Cocrystal structure
HER3, pseudokinase, hydrophobic tag degrader, Breast cancer, autophagy